Tryptamine(ASRI)
N/A
Report date: 2024/06/19 14:04:43
NME
Base Information
Drug NameTryptamine(ASRI)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlexander Shulgin Research Institute
China Registration ClassN/A
Develop Information
Active CompaniesAlexander Shulgin Research Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A